A phase I study of nab-paclitaxel (A), gemcitabine (GEM), and capecitabine (X) in patients with metastatic pancreatic adenocarcinoma (MPA).
Thach-Giao Truong
No relevant relationships to disclose
Margaret A. Tempero
Consultant or Advisory Role - Celgene
Emily Kantoff
No relevant relationships to disclose
Kimberly Jones
No relevant relationships to disclose
Elizabeth Dito
No relevant relationships to disclose
Anna Ong
No relevant relationships to disclose
Andrew H. Ko
Research Funding - Celgene